RESUMO
BACKGROUND: In Uganda, village health workers (VHWs) manage childhood illness under the integrated community case management (iCCM) strategy. Care is provided for malaria, pneumonia, and diarrhoea in a community setting. Currently, there is limited evidence on the cost-effectiveness of iCCM in comparison to health facility-based management for childhood illnesses. This study examined the cost-effectiveness of the management of childhood illness using the VHW-led iCCM against health facility-based services in rural south-western Uganda. METHODS: Data on the costs and effectiveness of VHW-led iCCM versus health facility-based services for the management of childhood illness was collected in one sub-county in rural southwestern Uganda. Costing was performed using the ingredients approach. Effectiveness was measured as the number of under-five children appropriately treated. The Incremental Cost-Effectiveness Ratio (ICER) was calculated from the provider perspective. RESULTS: Based on the decision model for this study, the cost for 100 children treated was US$628.27 under the VHW led iCCM and US$87.19 for the health facility based services, while the effectiveness was 77 and 71 children treated for VHW led iCCM and health facility-based services, respectively. An ICER of US$6.67 per under five-year child treated appropriately for malaria, pneumonia and diarrhoea was derived for the provider perspective. CONCLUSION: The health facility based services are less costly when compared to the VHW led iCCM per child treated appropriately. The VHW led iCCM was however more effective with regard to the number of children treated appropriately for malaria, pneumonia and diarrhoea. Considering the public health expenditure per capita for Uganda as the willingness to pay threshold, VHW led iCCM is a cost-effective strategy. VHW led iCCM should, therefore, be enhanced and sustained as an option to complement the health facility-based services for treatment of childhood illness in rural contexts.
Assuntos
Administração de Caso , Agentes Comunitários de Saúde , Análise Custo-Benefício , População Rural , Uganda , Humanos , Agentes Comunitários de Saúde/economia , Administração de Caso/economia , Pré-Escolar , Lactente , Malária/economia , Malária/tratamento farmacológico , Diarreia/terapia , Diarreia/economia , Pneumonia/economia , Pneumonia/terapia , Instalações de Saúde/economia , Instalações de Saúde/estatística & dados numéricos , Recém-Nascido , Masculino , Feminino , Serviços de Saúde Comunitária/economiaRESUMO
Severe acute malnutrition (SAM) is a high-fatality condition that affected 13.7 million children under five years of age worldwide in 2022, with complicated cases requiring extensive inpatient stay with an accompanying caregiver. Our objective was to assess the costs of inpatient treatment for complicated SAM in children aged 6 to 59 months in Northern Senegal and identify cost predictors. We performed a retrospective cost analysis, including 140 children hospitalized from January to December 2020 in five SAM inpatient treatment facilities. We adopted a societal perspective, including direct medical and non-medical costs and indirect costs. We extracted patients' sociodemographic and clinical data from medical records and conducted semi-structured interviews with healthcare staff to capture information on time allocation and care management. A multivariable generalized linear model with gamma family and a log link was used to investigate the factors associated with direct costs. Costs are expressed in 2020 international USD using purchasing power parity. Mean length of stay was 5.3 (SD = 3.2) days and diarrhoea was the cause of the admission in 55.7% of cases. Mean total cost was USD 431.9 (SD = 203.9), with personnel being the largest cost item (33% of the total). Households' out-of-pocket expenses represented 45.3% of total costs and amounted to USD 195.6 (SD = 103.6). Costs were significantly associated with gender (20.3% lower in boys), diarrhoea (27% increase), anaemia (49.4% increase), inpatient death (44.9% decrease), and type of facility (26% higher in hospitals vs. health centre). Our study highlights the financial burden of complicated SAM in Senegal in particular for families. This underscores the need for tailored prevention and social policies to protect families from the disease's financial burden and improve treatment adherence, both in Senegal and similar contexts.
Assuntos
Efeitos Psicossociais da Doença , Desnutrição Aguda Grave , Humanos , Senegal , Lactente , Masculino , Feminino , Pré-Escolar , Desnutrição Aguda Grave/economia , Desnutrição Aguda Grave/terapia , Estudos Retrospectivos , Hospitalização/economia , Tempo de Internação/economia , Pacientes Internados/estatística & dados numéricos , Custos e Análise de Custo , Custos de Cuidados de Saúde/estatística & dados numéricos , Gastos em Saúde/estatística & dados numéricos , Diarreia/economia , Diarreia/terapiaRESUMO
INTRODUCTION: Objective assessment of treatment effectiveness using real-world claims data is challenging. This study assessed treatment-free intervals (TFI) as a proxy for treatment effectiveness, and all-cause healthcare costs among adult patients with irritable bowel syndrome with diarrhea (IBS-D) treated with rifaximin or eluxadoline in the USA. METHODS: Adult patients (18-64 years) with IBS-D and ≥ 1 rifaximin or eluxadoline prescription were identified in the IQVIA PharMetrics® Plus database (10/01/2015-12/31/2021) and classified into two mutually exclusive cohorts (i.e., rifaximin and eluxadoline). Index date was the date of rifaximin or eluxadoline initiation. Entropy-balanced baseline characteristics, TFI (periods of ≥ 30 consecutive days without IBS-D treatment), and healthcare costs were reported. Healthcare costs were compared between cohorts using mean cost differences. RESULTS: There were 7094 and 2161 patients in the rifaximin and eluxadoline cohorts, respectively. After balancing, baseline characteristics (mean age 44.1 years; female 72.4%) were similar between cohorts. A higher proportion of patients treated with rifaximin achieved a TFI of ≥ 30 days (76.2% vs. 66.7%), ≥ 60 days (67.0% vs. 47.0%), ≥ 90 days (61.0% vs. 38.7%), ≥ 180 days (51.7% vs. 31.0%), and ≥ 240 days (47.7% vs. 27.9%) compared to eluxadoline. Among patients with a TFI ≥ 30 days, mean TFI durations were 8.3 and 6.0 months for the rifaximin and eluxadoline cohorts. Mean all-cause healthcare costs were lower for rifaximin vs. eluxadoline ($18,316 vs. $23,437; p = 0.008), primarily driven by pharmacy costs ($7348 vs. $10,250; p < 0.001). In a simulated health plan of one million commercially insured lives, initiating 50% of patients on rifaximin instead of eluxadoline resulted in total cost savings of $2.1 million per year or $0.18 per-member-per-month. CONCLUSIONS: This real-world study suggests that TFI is a meaningful surrogate measure of treatment effectiveness in IBS-D. Patients treated with rifaximin had longer treatment-free periods and lower healthcare costs than patients treated with eluxadoline.
Assuntos
Diarreia , Fármacos Gastrointestinais , Custos de Cuidados de Saúde , Síndrome do Intestino Irritável , Rifaximina , Humanos , Síndrome do Intestino Irritável/tratamento farmacológico , Síndrome do Intestino Irritável/economia , Adulto , Feminino , Masculino , Rifaximina/uso terapêutico , Diarreia/tratamento farmacológico , Diarreia/economia , Pessoa de Meia-Idade , Fármacos Gastrointestinais/uso terapêutico , Fármacos Gastrointestinais/economia , Adolescente , Adulto Jovem , Resultado do Tratamento , Custos de Cuidados de Saúde/estatística & dados numéricos , Fenilalanina/uso terapêutico , Fenilalanina/análogos & derivados , Fenilalanina/economia , Estados Unidos , Estudos Retrospectivos , ImidazóisRESUMO
Objetivo. Evaluar los costos médicos directos, gastos de bolsillo y costos indirectos en casos de diarrea aguda hospitalizada en <5 años, en el Hospital de Niños Héctor Quintana de la provincia de Jujuy, durante el período de circulación de rotavirus en la región Noroeste de Argentina. Métodos. Estudio de corte trasversal de costos de enfermedad. Fueron incluidos todos los niños hospitalizados <5 años con diagnóstico de diarrea aguda y deshidratación durante el período de circulación de rotavirus, entre el 1/5/2013 y el 31/10/2013. La evaluación de costos médicos directos se realizó mediante la revisión de historias clínicas, y los gastos de bolsillo y costos indirectos, mediante una encuesta. Para el intervalo de confianza del 95% del costo promedio por paciente, se realizó un análisis probabilístico de 10 000 simulaciones por remuestreo (boostraping). Resultados. Fueron enrolados 105 casos. La edad promedio fue de 18 meses (desvío estándar 12); 62 (59%) fueron varones. El costo médico directo, gasto de bolsillo y pérdida de dinero por lucro cesante promedio por caso fue de AR$ 3413, 6 (2856, 35-3970, 93) (USD 577, 59), AR$ 134, 92 (85, 95-213, 57) (USD 22, 82) y de AR$ 301 (223, 28380, 02) (USD 50, 93), respectivamente. El total del costo por evento hospitalizado fue de AR$ 3849, 52 (3298-4402, 25) (USD 651, 35). Conclusiones. El valor de costo total por evento hospitalizado se encuentra dentro de lo esperado para Latinoamérica. La distribución de costos presenta una proporción importante de costos médicos directos en relación con los gastos de bolsillo (3, 5%) y costos indirectos (7, 8%).
Objective. To assess direct medical costs, out-of-pocket expenses, and indirect costs in cases of hospitalizations for acute diarrhea among children <5 years of age at Hospital de Niños "Héctor Quintana" in the province of Jujuy during the period of rotavirus circulation in the Northwest region of Argentina. Methods. Cross-sectional study on disease-related costs. All children <5 years of age, hospitalized with the diagnosis of acute diarrhea and dehydration during the period of rotavirus circulation between May 1st and October 31st of 2013, were included. The assessment of direct medical costs was done by reviewing medical records whereas out-of-pocket expenses and indirect costs were determined using a survey. For the 95% confidence interval of the average cost per patient, a probabilistic bootstrapping analysis of 10 000 simulations by resampling was done. Results. One hundred and five patients were enrolled. Their average age was 18 months (standard deviation: 12); 62 (59%) were boys. The average direct medical cost, out-of-pocket expense, and lost income per case was ARS 3413.6 (2856.35-3970.93) (USD 577.59), ARS 134.92 (85.95-213.57) (USD 22.82), and ARS 301 (223.28380.02) (USD 50.93), respectively. The total cost per hospitalization event was ARS 3849.52 (32984402.25) (USD 651.35). Conclusions. The total cost per hospitalization event was within what is expected for Latin America. Costs are broken down into direct medical costs (significant share), compared to out-of-pocket expenses (3.5%) and indirect costs (7.8%).
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Infecções por Rotavirus/economia , Custos Diretos de Serviços , Efeitos Psicossociais da Doença , Diarreia/economia , Hospitalização/economia , Argentina , Infecções por Rotavirus/virologia , Estudos Transversais , Rotavirus , Desidratação/economia , Desidratação/virologia , Diarreia/virologia , Financiamento Pessoal/economiaRESUMO
Objetivo evaluar la costo-efectividad relativa del uso de vitamina a en los niños menores de 5 años en la disminución de eventos de diarrea, malaria y la mortalidad, bajo la perspectiva del sistema de salud colombiano (SGSSS). Materiales y Métodos se construyó unárbol de decisión con muertes evitadas como desenlace. Las probabilidades se extrajeron de la literatura y los costos de fuentes oficiales. El umbral de costo-efectividad fue tres veces el producto interno bruto (PIB) per cápita colombiano de 2012. Se realizaron análisis de sensibilidad determinísticos, probabilísticos y curva de aceptabilidad. Resultados En una cohorte de cien mil niños, la administración de vitamina a, frente no hacerlo, representaría un ahorro en costos de atención médica de $ 340.306.917, debido a que reduce el número de eventos de diarrea (4.268) y de malaria (76), así como los casos en los que se requiere hospitalización. En todos los análisis de sensibilidad se obtuvo un ahorro para el sistema. Conclusión Dentro del sistema de salud colombiano, la suplementación con vitamina a para niños menores de 5 años, comparado con no hacerlo, es la estrategia menos costosa y más efectiva (dominante).
Objective Evaluating the relative cost-effectiveness of using vitamin A in children aged less than 5-years-old regarding the reduction of events involving diarrhoea, malaria and mortality from the Colombian health-related social security system (CHSSS). Materials and Methods A decision tree was constructed, using deaths averted as outcome. Probabilities were taken from the pertinent literature and costs from official sources. The cost-effectiveness threshold was three times greater than the per capita Colombian gross domestic product (GDP) in 2012. Probabilistic and deterministic sensitivity analyses were made and cost effectiveness acceptability curves were drawn. Results Providing a cohort of 100,000 children with vitamin A (as opposed to not doing so) would represent a saving regarding medical attention costs of $ 340,306,917 due to the number of events involving diarrhea (4,268) and malaria (76), having become reduced, as well as cases requiring hospitalization. A saving for the CHSSS was consistently obtained in sensitivity analysis. Conclusion Providing vitamin supplements for children aged less than 5 years-old would seem to be the least costly and most effective (dominant) strategy for the CHSSS, i.e. compared to not doing so).
Assuntos
Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Análise Custo-Benefício , Diarreia/prevenção & controle , Suplementos Nutricionais , Malária/prevenção & controle , Deficiência de Vitamina A/prevenção & controle , Vitamina A/uso terapêutico , Vitaminas/uso terapêutico , Colômbia/epidemiologia , Árvores de Decisões , Diarreia/economia , Diarreia/etiologia , Diarreia/mortalidade , Suplementos Nutricionais/economia , Custos de Medicamentos/estatística & dados numéricos , Malária/economia , Malária/etiologia , Malária/mortalidade , Programas Nacionais de Saúde/economia , Resultado do Tratamento , Deficiência de Vitamina A/economia , Deficiência de Vitamina A/etiologia , Vitamina A/economia , Vitaminas/economiaAssuntos
Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino , Infecções por Protozoários/epidemiologia , Condições Sociais , Saúde Ambiental , Helmintíase/epidemiologia , Enteropatias Parasitárias/epidemiologia , Organização Pan-Americana da Saúde , Infecções por Protozoários/complicações , Infecções por Protozoários/economia , Região do Caribe , Desnutrição/economia , Desnutrição/etiologia , Desnutrição/epidemiologia , Diarreia/economia , Diarreia/etiologia , Diarreia/epidemiologia , Escolaridade , Eficiência , Helmintíase/complicações , Helmintíase/economia , Renda , Enteropatias Parasitárias/complicações , Enteropatias Parasitárias/economia , América LatinaRESUMO
Objetivo. Generar información sobre los costos de producción de servicios de salud. Material y métodos. Siguiendo los criterios de Kessner se seleccionaron como trazadores: hipertensión, diabetes, diarreas y neumonías. Posteriormente, se definió el manejo de casos y, por medio de la metología de costeo por manejo de caso, se definieron las funciones de producción, así como los insumos y costos unitarios requeridos para satisfacer la demanada de servicios médicos de cada enfermedad. Se procesaron los datos en una hoja de cálculo para identificar los costos de manejo de casos hospitalarios y ambulatorios para cada enfermedad de estudio es posible identificar el peso relativo, tanto de las distintias funciones de producción, como de los diferentes tipos de insumos. Dependiendo de las frecuencias relativas, tanto insumos como funciones de producción se clasificaron en alto, medio y bajo impacto sobre el costo total de manejo de caso Conclusiones. A partir de la información generada se sugiere replantear los procesos de planeación, organización y asignación de recursos, en función de demandas de servicios hospitalarios y ambulatorios para cada trazador. Asimismo, se sugieren acciones para propiciar ganancias económicas en la utilización de recursos y en el uso más eficiente de los mismos
Assuntos
Humanos , Criança , Adulto , Doenças Transmissíveis , Doenças Transmissíveis/economia , Custos Hospitalares , Diabetes Mellitus/economia , Diarreia/economia , Assistência Ambulatorial/economia , Necessidades e Demandas de Serviços de Saúde/economia , México , Custos e Análise de Custo , Doença Crônica/economia , Doença Crônica/epidemiologia , Hipertensão/economia , Pneumonia/economiaRESUMO
Objetivo. Abordar el análisis de costos de servicios de salud en eventos trazadores para instituciones de los sectores público y privado en México. Material y métodos. A partir de las funciones de producción y los insumos requeridos para el manejo de casos estándar de cada enfermedad o evento, se procedió a hacer el ajuste en el manejo de los trazadores para cada institución, mediante la técnica de consenso y con la participación de expertos por institución. Identificados los insumos y cantidades para la producción de servicios especificos de salud, se determinaron los costos de manejo de caso. Como trazadores se seleccionaron: hipertensión, diabetes, diarreas, neumonías, apendicectomía, atención del parto, consulta típica y vacunas. Se incluyeron tres instituciones del sector público y cinco del sector privado. Resultados. Los resultados indican que al determinar y comparar el costo de manejo de caso para cada trazador existen diferencias significativas para fines de producción de servicios médicos entre ambos sectores y al interior de cada uno. Conclusiones. El análisis comparativo en el costo de manejo de caso para cada trazador, presenta diferencias que se explican por procesos cualitativos y cuantitativos que caracterizan a cada institución en la combinación de insumos para producir servicios y por los distintos costos de insumos para cada uno de los sectores analizados, resultando los costos más bajos en instituciones del sector público, particularmente en la Secretaría de Salud, y los costos más altos en el sector privado, particularmente en seguros médicos privados
Objective. To approach the cost analysis of the health services for eight tracer conditions, in three institutions of the public sector and in five of the private sector. Material and Methods. First, production functions and inputs required for standard case-management of each tracer condition were identified. Subsequently, tracer case-management was adjusted for each institution through expert consensus techniques. Once the type and amount of inputs necessary to produce tracer-specific health care services were identified, case-management costs were estimated. Tracer conditions were: hypertension, diabetes, diarrheas, pneumonia, appendicectomy, labor and delivery care, routine ambulatory medical care and vaccines. Results. Results indicate significant differences with regards to the production of medical services between both sectors and within each one. Conclusions. The comparative analysis in the cost per case-management for each tracer presents differences that could be explained due to the quantitative and qualitative processes that characterized each institution in the combination of inputs to produce services and for the different costs of the inputs for each of the sectors analyzed, resulting in lower costs in the public sector and higher costs in the private sector, particularly for private health insurance.
Assuntos
Humanos , Apendicectomia/economia , Setor Privado/economia , Parto/economia , Diabetes Mellitus/economia , Diarreia/economia , Serviços de Saúde/economia , Custos de Cuidados de Saúde , Custos e Análise de Custo/métodos , Hipertensão/economia , Imunização/economia , Pesquisa sobre Serviços de Saúde/métodos , Pneumonia/economia , Encaminhamento e Consulta/economia , Setor Público/economiaRESUMO
The treatment received by children aged under 5 years with diarrhoea was studied in the Hospital Infantil de México (Federico Gómez), Mexico City. The costs of treatment were calculated and estimates were made of how these had changed since the establishment of an oral rehydration unit in the hospital in 1985. The results indicate that drug treatment of outpatients was generally appropriate and inexpensive. In contrast, the cost of drugs for inpatients was considerably higher. The seriousness of the cases justified much of this additional expense for inpatients, but there is evidence that the costs could be reduced further without jeopardizing the quality of the care. Diagnostic tests were relatively expensive, frequently failed to identify diarrhoeal etiology, and their results correlated poorly with the treatment prescribed. The oral rehydration unit resulted in significant savings by causing a 25 per cent fall in the number of inpatients with diarrhoea(AU)